Proton Pump Inhibitors
Infecções hospitalares relacionadas ao uso de inibidores da bomba de prótons / Hospital infections related to the use of Proton Pump Inhibitors
... “Proton Pump Inhibitors”, “risks”, “hospital Infection” e “nosocomial infection”, todos presentes nos Descritores em Ciências da Saúde (DeCS) e Medical Subject Headings (MeSH) e utilizados com os ...
16
Proton pump inhibitors in patients treated with aspirin and clopidogrel after acute coronary syndrome
... ABSTRACT Introduction: Clopidogrel is an antiplatelet agent converted to its active metabolite by cytochrome P-450 isoenzymes. Numerous drugs are known to inhibit P-450 isoen- zymes, including proton pump ...
10
The Interaction of Clopidogrel and Proton Pump Inhibitors
... 2. Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, et al. Risk of ad- verse outcomes associated with concomittant use of clopidogrel and proton pump inhibitors following acute coronary ...
3
Proton pump inhibitors increase the overall risk of developing bacterial infections in patients with cirrhosis
... infections. Proton pump inhibitors (PPI) are frequently prescribed in patients with cirrhosis, but is unclear if PPI are associated with the development of bacterial infections in these ...
5
Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
... Metformin, an oral insulin-sensitizing drug, is actively transported into cells by organic cation transporters (OCT) 1, 2, and 3 (encoded by SLC22A1, SLC22A2, or SLC22A3), which are tissue specifically expressed at ...
11
Effect of proton pump inhibitors on in vitro activity of tigecycline against several common clinical pathogens.
... In this study, we evaluated the effect of proton pump inhibitors (PPIs) on in vitro antimicrobial activity of tigecycline against several species of clinical pathogens. Clinical non-duplicate ...
4
Unexplained abdominal pain as a driver for inappropriate therapeutics: an audit on the use of intravenous proton pump inhibitors
... Proton pump inhibitors (PPIs) are currently the most effective agents for acid-related disorders. The high degree of acid suppression by PPIs make these drugs an ideal option in the treatment of ...
12
Is there an overprescription of proton pump inhibitors in oncohematologic patients undergoing ambulatory oncospecific treatment?
... This age difference could ge- nerate a confusion bias in the analysis of outcomes, because patients older than 70-year-old are more fre- quent among the hematologic population, and this[r] ...
11
The relationship between proton pump inhibitors and renal disease
... 4,14 Apesar de infrequentes, há evidências crescentes de eventos adversos relacionados aos IBPs, como fraturas ósseas, pneumonia, demência, hipomagnesemia e doenças renais, como nefri[r] ...
6
Arq Bras Endocrinol Metab vol.58 número7
... zole usage, such as dyspepsia, gastroesophageal relux or peptic ulcer. Exclusion criteria included the follow- ing: 1) diseases or conditions associated with malab- sorption, including celiac disease, intestinal ...
6
Arq. Gastroenterol. vol.54 número4
... dietary treatment, it has been observed that the recovery can happen through elimination diet by eliminating only the cow milk protein. Thus, in the treatment of eosinophilic esophagitis, which is a recurrent chronic ...
2
Dietary Inulin Fibers Prevent Proton-Pump Inhibitor (PPI)-Induced Hypocalcemia in Mice.
... ago, proton pump inhibitors (PPIs) became the mainstay in gastro esophageal reflux (GERD), peptic ulcer disease (PUD), persistent non-steroidal anti- inflammatory drug (NSAID) treatment and ...
13
PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis.
... of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointes- tinal risks of antiplatelet therapy and NSAID use: a ...
13
Arq. Gastroenterol. vol.49 número4
... the proton pump inhibitors ...to proton pump inhibi- tors treatment but 20%-42% of them may not do so ...with proton pump inhibitors (omeprazole, pantoprazole, ...
6
Prolonged gastroesophageal reflux monitoring by impedance-pHmetry: a review of the subject pondered with our experience with 1,200 cases
... of proton pump inhibitors (PPIs); evaluation of patients with symptoms suggestive of GERD although with normal endoscopy and normal pHmetry, diagnostic elucidation of patients with atypical symptoms ...
9
Arq. Gastroenterol. vol.54 número4
... – Proton pump inhibitors and histamine H2 receptor antagonists are two of the most commonly prescribed drug classes for pediatric gastroesophageal relux disease, but their eficacy is ...of ...
10
J. Pediatr. (Rio J.) vol.82 número5 suppl. en v82n5s0a03
... Summary of the findings: The drugs currently available for the treatment of GERD do not act in the primary mechanism of the disease, i.e., transitory relaxation of the lower esophageal sphincter. Pharmacological ...
13
Predictores de Prescrio Inadequada de Inibidores da Bomba de Protes num Servio de Medicina Interna
... Introduction: Proton pump inhibitors (PPIs) are used in the treatment of gastrointestinal pathology and prevention of up- per gastrointestinal bleeding. They are frequently misused in [r] ...
7
(São Paulo, online) vol.3 número4
... of proton pump inhibitors and colon polyps; no association was reported; similarly, we found no differences between groups in terms of PPI ...
5
Inibidores da Bomba de Protes na Profilaxia da lcera de Stress em Doentes No Crticos
... Introduction: The use of proton pump inhibitors (PPIs) has a well-established role in the prophylaxis of gastrointestinal bleeding in critically care patients; however, its use in non[r] ...
5